The Cantley lab welcomes a diverse set of talents and fosters an interdisciplinary approach in its attempts to translate fundamental scientific discoveries into clinical innovations.
Lewis C. Cantley, Ph.D.
Jacqueline Gonzalez B.Sc.
Administrative Assistant to Dr. Lewis Cantley
Monica Rosen B.S.
Kaitlyn Bosch B.S.
Research Focus: GEMMs in colorectal cancer and cancer metabolism
Gina M. DeNicola Ph.D.
Research Focus: NRF2 Activity in Pancreatic Cancer
Brooke M. Emerling Ph.D.
Instructor of Cancer Biology
Research Focus: The Role of the Phosphatidylinositol 5-Phosphate 4-Kinases in p53 Null Breast Cancers
Marcus Goncalves M.D., Ph.D.
Research Focus: Skeletal muscle growth and metabolism, Muscle loss in cancer, Glucose metabolism, Insulin signaling, PI5P4K
Cindy Hodakoski Ph.D.
Research Focus: Studying glucose dependence and AMPK signaling regulation in lung cancer cells.
Ben Hopkins Ph.D.
Research Focus: The role of insulin signaling in pancreatic cancer; how insulin signaling impacts KRAS driven disease progression and how these signaling networks can be targeted for therapeutic benefit.
Jared Johnson Ph.D.
Research Focus: Molecular and biochemical approaches to the signaling and metabolism of cancers
Florian Karreth Ph.D.
Research Focus: The role of competitive endogenous RNAs in cancer as well as on the identification of mediators of prostate cancer bone metastasis.
Ting-Yu (Molly) Lin
Research Focus: Regulation of NRF2 in the Non-Small Cell Lung Cancer (NSCLC).
Ryan Loughran B.S.
Valbona Luga Ph.D.
Research Focus: LKB1/AMPK Signaling and Peutz-Jeghers Syndrome
Mark Lundquist Ph.D.
Research Focus: How extracellular stimuli drive dynamic changes in cytosolic and nuclear structure, and how those changes lead to gene transcription in disease such as breast cancer, pancreatic cancer and melanoma.
Research Focus: Investigating novel PDAC therapies.
Visiting Graduate Student
Research Focus: Cancer cell metabolism with a focus on the serine synthesis pathway.VIVO Researcher Profile
Research Focus: (1) Defining the molecular basis of LKB1-HIPPO pathway mediated tumor suppression in KRAS-Driven Non-Small Cell Lung Cancer. (2) Identifying molecular convergence points between the Hippo Pathway and Phosphoinositide (PI) Kinases, with an emphasis on the Type II PI Kinase, PIP4K2s.
Evan Noch M.D., Ph.D.
Research Focus: The role of oncogenes in the regulation of oxygen and glucose metabolism in the pathogenesis of glioblastoma and medulloblastoma.
Research Focus: Analysis of the biochemistry behind folate metabolism in cell growth.
Visiting Graduate Student
Research Focus: Identifying the role of PIP4K2C in vivo and developing type II PIP4K inhibitors
M.D., Ph.D. student
Research Focus: Pancreatic adenocarcinoma, PIP4K, metabolomics, kras, radiometabolomics
Research Focus: Kinase signaling and developing drugs to target the phosphoserine pathway.
David Wu B.S.
Research Focus: Maintaining mouse colonies and mouse experiments
Zhiwei Yang B.S.
Jonathan Yang M.D.
Radiation Oncology Fellow
Research Focus: Development of a therapeutic protocol and exploring the radiosensitizing mechanisms of PI5P4K inhibition in breast cancer.
Jihye Yun Ph.D.
Research Focus: Metabolic pathways and enzyme regulation by oncogenes in colorectal cancer